Centauri Therapeutics develops immunotherapy treatments for infectious diseases using their Alphamer technology to target Gram-negative and Multi-Drug Resistant bacteria.

Glox Therapeutics develops precision antibiotics targeting drug-resistant bacteria, with a focus on creating high-potency bacteriocins to selectively target and kill antibiotic-resistant Gram-negative pathogens while preserving the patient's microbiome.

ArrePath, Inc. is a biotechnology company developing novel antibiotics using AI/ML technology to combat multidrug-resistant bacterial infections.

Trolley is a global payouts platform that helps businesses manage international payments, tax compliance, and ID verification.